About
QuidelOrtho Corporation brings together the strength of Quidel Corporation and Ortho Clinical Diagnostics behind a shared mission to develop and manufacture innovative technologies that increase the effectiveness of diagnostic tests and create better patient outcomes across the healthcare continuum.
Ranked among the world’s largest in vitro diagnostic (IVD) providers, QuidelOrtho builds on more than 120 years of collective experience and innovation. Combine industry-leading expertise in immunoassays and molecular testing with a global footprint in point-of-care, clinical laboratories and transfusion medicine to advance critical diagnostic solutions at scale.
Products
At the center of our automated solution is the Ortho Vision Swift Platform, an award-winning, industry-leading, automated pretransfusion testing system.
Ortho Vision Swift can automate more than 99% of blood typing and antibody screening, without compromising turnaround time. Swift analyzers have the most diverse testing capabilities on the market today, including serial dilutions for titration studies, selected cell panels and open channels.